Gateway Investment Advisers LLC Takeda Pharmaceutical CO LTD Transaction History

Gateway Investment Advisers LLC

  • $9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 15, 2019
SELL
$16.15 - $17.99 $610,033 - $679,536
-37,773 Closed
0 $0
Q2 2019

Jul 17, 2019
SELL
$16.58 - $20.49 $2.67 Million - $3.29 Million
-160,741 Reduced 80.97%
37,773 $669,000
Q1 2019

Apr 10, 2019
BUY
$16.7 - $21.52 $3.32 Million - $4.27 Million
198,514 New
198,514 $4.04 Million

Others Institutions Holding TAK

# of Institutions
320
Shares Held
70.4M
Call Options Held
939K
Put Options Held
233K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Gateway Investment Advisers LLC Portfolio

Follow Gateway Investment Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email